Dalteparin sodium is mainly used for hemodialysis or filtration to prevent blood clotting and thrombosis during cardiopulmonary bypass. The drug is mainly used in hemodialysis for the prevention of clotting, as well as the treatment of deep vein thrombosis, unstable angina pectoris, and the prevention of operation-related thrombosis.

　　Needs to be individualized dosage, in terms of dosage of the drug in the application process may produce adverse reaction, can lead to bleeding, especially large dose application that may lead to subcutaneous hematoma, may also cause thrombocytopenia, skin necrosis, allergic reactions, rare is likely to trigger transaminase lifts.

　　The drug also has contraindications in the application process. It is prohibited for patients with acute gastroduodenal ulcer, cerebral hemorrhage, severe coagulation disease, and septic endocarditis. Heparin is contraindicated in patients with thrombocytopenia whose platelet aggregation test is positive in vitro for central nervous system ocular and ear injuries or for surgical use. In the treatment of acute pulmonary thrombosis, local anesthetic drugs must be used with caution.

　　Qingdao Jiulong Group is a heparin manufacturer,Chondroitin Sulfate Sodium manufacturer and heparin sodium API supplier. Production of heparin sodium, enoxaparin sodium, heparinoid, dalteparin sodium,chondroitin sulfate and so on. Welcome to consult heparin sodium price! T